Advertisement

Topics

MEDITE Cancer Diagnostics, Inc. Company Profile

13:59 EDT 18th September 2018 | BioPortfolio

MEDITE Cancer Diagnostics Inc., is a Delaware registered company consisting of wholly-owned MEDITE GmbH a Germany-based Company, with its subsidiaries CytoGlobe GmbH (Cytology Products, Germany), MEDITE GmbH (Distributor, Austria), MEDITE Inc. (Distributor, Americas) and MEDITE sp. z o.o. (R&D Poland). MEDITE specializes in the development, manufacture and distribution of medical laboratory automation equipment and supplies for pathology, histology and cytology. For these fields, it offers a complete range of devices and consumables. MEDITE currently sells into 70 countries and is the market leader in Germany. Additional information on MEDITE’s products and services can be found at www.medite-group.com. On April 3, 2014, MEDITE was acquired by CytoCore, Inc. a bio molecular diagnostics company engaged in the design, development, and commercialization of cost-effective cancer screening systems and immune-assays to assist in the early detection of cancer. The name of the company changed from CytoCore, Inc. to MEDITE Cancer Diagnostics, Inc. in December 2014.


News Articles [2207 Associated News Articles listed on BioPortfolio]

How Sienna Cancer Diagnostics are translating telomerase into a cancer biomarker.

Cliff Holloway, CEO to Sienna Cancer Diagnostics, discusses the development and commercialisation of SCE-A7, the first telomerase detection product.

Global Kidney Cancer Therapeutics & Diagnostics Market (2018-2023): Rising Number of Kidney Cancer Cases is Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Kidney Cancer Therapeutics & Diagnostics Market – Segmented by Cancer Type, Therapy, Diagnostics, End-users, and Geography – Growt...

Grail Raises $300 Million from China Investors for Early Cancer Diagnostics

Grail, a Hong Kong-US oncology diagnostics company, announced a $300 million C financing. Since early 2016, Grail has raised over $1.5 billion. The company is sequencing large populations of people --...

A New Wave of Early Cancer Diagnostics is On Its Way

Recent studies in early diagnostics underline just how much focus medical technology companies are making on developing different modalities for very early cancer diagnosis. Here are just some recent ...

MEDITE Cancer Diagnostics Inc MDIT Medical Equipment Deals and Alliances Profile [Report Updated: 12072018] Prices from USD $250

SummaryMEDITE Cancer Diagnostics Inc MEDITE, formerly CytoCore, Inc., specializes in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection,...

MEDITE Cancer Diagnostics Inc MDIT Medical Equipment Deals and Alliances Profile [Report Updated: 24042018] Prices from USD $250

SummaryMEDITE Cancer Diagnostics Inc MEDITE, formerly CytoCore, Inc., specializes in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection,...

Accelerating the development of new cancer therapies; Ketil Widerberg, General Manager, Oslo Cancer Cluster

Four out of ten people will be diagnosed with cancer during their life and it is crucial to develop new diagnostics and medication. Oslo Cancer Cluster is an oncology research and industry cluster de...

True Health Diagnostics Showcases Its Commitment to Educating Doctors, Patients About Hereditary Cancer During Breast Cancer Awareness Month

FRISCO, Texas , Oct. 11, 2017 /- True Health, a leader in integrated diagnostics and healthcare services, has amplified its effort during National Breast Cancer Awareness month to educate doctor...

PubMed Articles [6212 Associated PubMed Articles listed on BioPortfolio]

Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics.

The importance of medical imaging in the diagnosis and monitoring of cancer cannot be overstated. As personalized cancer treatments are gaining popularity, a need for more advanced imaging techniques ...

Tissue Preservation with Mass Spectroscopic Analysis: Implications for Cancer Diagnostics.

Surgical intervention is a common treatment modality for localized cancer. Post-operative analysis involves evaluation of surgical margins to assess whether all malignant tissue has been resected beca...

The influence of different fever definitions on diagnostics and treatment after diagnosis of fever in chemotherapy-induced neutropenia in children with cancer.

There is no evidence-based definition of the temperature limit defining fever (TLDF) in children with neutropenia. Lowering the TLDF is known to increase the number of episodes of fever in neutropenia...

Breast Cancer: Diagnostics and Therapy - the Most Important Facts for Internists.

 After reviewing this article, the participant should be able to: 1. Understand the epidemiology of breast cancer, its incidence and impact. 2. Appreciate the importance of early diagnosis and treat...

Dizziness and vertigo associated with vestibular neuronitis: the approaches to the diagnostics and treatment.

This article is focused on the peculiar features of diagnostics and treatment of dizziness and vertigo in the patients presenting with vestibular neuronitis. The authors present the detailed overview ...

Clinical Trials [8530 Associated Clinical Trials listed on BioPortfolio]

Diagnostics and Therapy of Disease-Related Quality of Life of Patients With Breast Cancer

Quality of Life-Diagnostics and -Therapy in Individual Patients with Breast Cancer. A randomized study including 200 patients, 5 clinics and 43 general practitioners as coordinating docto...

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

Non-Invasive Diagnostics of Small Renal Masses

NiSAR is a Ph.D. study and consists of three substudies. Renal cancer is one of the most deadly urologic malignancies and accounts for 900 new cases and 300 deaths per year. An increase in...

Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100)

Major Research Aim: To study novel molecular diagnostics and the pharmacokinetic variability among a spectrum of TB disease states, including severe forms of TB like disseminated TB, TB me...

Implementation of Quality of Life Diagnostics and Therapy

Implementation and Evaluation of Implementation of Quality of Life Diagnostics and Therapy in Individual Patients with Breast Cancer. A prospective study including 170 patients, 5 clinics ...

Companies [2292 Associated Companies listed on BioPortfolio]

MEDITE Cancer Diagnostics, Inc.

MEDITE Cancer Diagnostics Inc., is a Delaware registered company consisting of wholly-owned MEDITE GmbH a Germany-based Company, with its subsidiaries CytoGlobe GmbH (Cytology Pro...

Cleveland Diagnostics, Inc.

Cleveland Diagnostics, Inc., is a clinical-stage biotechnology company developing technology to improve cancer diagnostics. Its Solvent Interaction Analysis (SIA) technology inves...

Acuamark Diagnostics, Inc.

Acuamark Diagnostics is a biotechnology company focused on developing screening tests for blood-based early detection of cancer. Acuamark Diagnostics' technology allows for highly...

Fujirebio Diagnostics, Inc.

Fujirebio Diagnostics, Inc., a subsidiary of Fujirebio Holdings, Inc., is the premier cancer diagnostics company and the industry leader in cancer biomarker assays. The company pi...

JFK Communications, Inc.

Fujirebio Diagnostics is the premier cancer diagnostics company and the industry leader in cancer biomarker assays. Fujirebio Diagnostics specializes in the clinical development, manufacturing and co...

More Information about "MEDITE Cancer Diagnostics, Inc." on BioPortfolio

We have published hundreds of MEDITE Cancer Diagnostics, Inc. news stories on BioPortfolio along with dozens of MEDITE Cancer Diagnostics, Inc. Clinical Trials and PubMed Articles about MEDITE Cancer Diagnostics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MEDITE Cancer Diagnostics, Inc. Companies in our database. You can also find out about relevant MEDITE Cancer Diagnostics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...


Corporate Database Quicklinks



Searches Linking to this Company Record